Full Press Release Details
Solid Biosciences Outlines Strategy Leadership Precision Genetic.
SLDB
Solid Biosciences Outlines Strategy Leadership Precision Genetic
Key Takeaway: Solid Biosciences Outlines Strategy Leadership Precision Genetic
Price reaction · baseline $6 (2023-01-09 close) · hit after-hours · 1 other SLDB headline(s) in the window, move may be shared
day 0 close
-0.8%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma